Osutidine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOsutidine
Drug Alias NameT-593Osutidine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonists
TargetsHistamine H2 receptor
Therapy Area/IndicationsStomach UlcerDuodenal Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesToyama Chemical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToyama Chemical Co Ltd
Active IndicationsN/A
Inactive IndicationsStomach UlcerDuodenal Ulcer

Other Information

ATC CodeN/A
Related LinksKEGG